• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

A comparative study to evaluate the effect of sclerotherapy in grade I and grade II internal haemorroids with Sodium tetradecyl sulphate (STD) and 50% Dextrose water

    Dr Praveen Singh Baghel , Dr Seema Suryavanshi, Dr Manish Agrawal, Dr Sudin Naag, Dr Dhananjay Sharma

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 4756-4763

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Hemorrhoidectomy is the procedure of choice for treating hemorrhoids most effectively. Now a day’s the emphasis is on conservative therapies and newer outpatient methods for treating hemorrhoids.
 Material and Methods: In 2 non-consecutive series of 50 patients, sodium tetradecyl sulphate and 50% dextrose water were injected. Dextrose is used as a 50% concentration (not diluted), while sodium tetradecyl sulphate is diluted 1:2 with distil water before administration.
 Results: Total 127 patient were recruited , Sodium Tetradecyl Sulphate(std) group 63 patients were selected and in dextrose 50% group 63 patients were selected. Mean age of std group was 38.75 years and d50% group was 39.5 years. Peak incidence of disease is between age group 20 to 50 years. Mean  number of sessions required of STD – 1.61(±0.60), Mean  number of sessions required of D50% - 2.40(±0.49) t =6.52 ; p  <0.0001 The mean sessions of sclerotherapy required for D50% group was significantly higher.
 Conclusion: STD performs better than D50%. Within 12 weeks, no sclerotherapy patients relapsed. Sclerotherapy has been well. Neither patient objected to therapy. No patient objected to a second or third injection. Sodium tetra decyl sulphate was more expensive than 50% dextrose sclerotherapy. Dextrose 50% requires multiple sessions. Our low-income patients mostly accepted government-funded care. Dextrose 50% may be preferable for sclerotherapy.
Keywords:
    sclerotherapy Hemorrhoids Bleeding Prolapsed
  • PDF (222 K)
  • XML
(2022). A comparative study to evaluate the effect of sclerotherapy in grade I and grade II internal haemorroids with Sodium tetradecyl sulphate (STD) and 50% Dextrose water. European Journal of Molecular & Clinical Medicine, 9(7), 4756-4763.
Dr Praveen Singh Baghel , Dr Seema Suryavanshi, Dr Manish Agrawal, Dr Sudin Naag, Dr Dhananjay Sharma. "A comparative study to evaluate the effect of sclerotherapy in grade I and grade II internal haemorroids with Sodium tetradecyl sulphate (STD) and 50% Dextrose water". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 4756-4763.
(2022). 'A comparative study to evaluate the effect of sclerotherapy in grade I and grade II internal haemorroids with Sodium tetradecyl sulphate (STD) and 50% Dextrose water', European Journal of Molecular & Clinical Medicine, 9(7), pp. 4756-4763.
A comparative study to evaluate the effect of sclerotherapy in grade I and grade II internal haemorroids with Sodium tetradecyl sulphate (STD) and 50% Dextrose water. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 4756-4763.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 3
  • PDF Download: 10
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus